Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers
Open Access
- 12 March 2021
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 30 (3) , 195-203
Abstract
Background: An early first full-time pregnancy substantially reduces the risk of developing breast cancer later in life. Extensive studies indicate that this protective effect is mediated by the pregnancy hormone human chorionic gonadotrophin (hCG). Methods: In this proof-of-concept study 33 women with a BRCA mutation received recombinant-hCG (r-hCG). A 4-mm breast biopsy was obtained before (T1) and after 12 weeks of r-hCG injections (T2), as well as 6 months later (T3). The tissue was examined using RNA-sequencing methodology to determine if the ‘high-risk’ transcriptomic signature was converted to a ‘low-risk’ signature as in an early first full-time pregnancy. A stringent clinical safety monitoring was performed. Results: The r-hCG administration was well tolerated in all participants. No clinically relevant changes were observed. In 25 women, the RNA quality was good for RNA sequencing in all three breast tissue biopsies. In response to the r-hCG, we observed 1907 differentially expressed genes (DEGs) (1032 up, 875 down) at T2 vs. T1 and 1065 DEGs (897 up, 168 down) at T3 vs. T1 in the group of women (n = 11) not using any hormonal contraceptives during the study. There was no response at T2 vs. T1 and a small number of DEGs, 260 (214 up, 46 down) at T3 vs. T1 in the group of 14 women using contraceptives. Conclusions: In summary, r-hCG has a remarkable effect on the gene expression profile of breast tissues from BRCA1/2 carriers who did not use any contraception. This opens an opportunity for a novel preventive strategy to reduce the incidence of breast cancer.Keywords
This publication has 23 references indexed in Scilit:
- Calculating Sample Size Estimates for RNA Sequencing DataJournal of Computational Biology, 2013
- Defining the genomic signature of the parous breastBMC Medical Genomics, 2012
- Reproductive history and breast cancer riskBreast Cancer, 2012
- Pregnancy‐induced chromatin remodeling in the breast of postmenopausal womenInternational Journal of Cancer, 2011
- Use of the immature rat uterotrophic assay for specific measurements of chorionic gonadotropins and follicle-stimulating hormones in vivo bioactivitiesTheriogenology, 2010
- Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 β‐estradiol in human breast epithelial cellsCell Biology International, 2009
- Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell deathCarcinogenesis, 1997
- Parity, age at first and last birth, and risk of breast cancer: A population-based study in SwedenBreast Cancer Research and Treatment, 1996
- Effect of human chlorionic gonadoropin on mammary gland differentiation and carcinogenesisCarcinogenesis, 1990
- Human chorionic gonadotrophin: Comparative studies of ovarian uptake in mammalsComparative Biochemistry and Physiology Part A: Physiology, 1975